Skip to content

CTEV CTEV EV / EBITDA

EV / EBITDA at other companies

UnitedHealth Group logo
UnitedHealth GroupUNH
12.8×-1.3×
Evolent Health, Inc. logo
Evolent Health, Inc.EVH
24.5×-26.3×
Corvel logo
CorvelCRVL
14.8×-22.5×
ROP
Roper Technologies, Inc.ROP
14.6×-9.9×
Cognizant logo
CognizantCTSH
7.4×-2.9×
Phreesia logo
PhreesiaPHR
17.3×

Other financials

Income statement

See full
Revenue$244.7M+5.8%
Gross profit$175.6M+2.8%
Operating income$6.6M-31.9%
Net income-$73.6M-3.1%
EPS (diluted)-$4.41-0.7%

Balance sheet

See full
Cash & equivalents$34.7M+2.4%
Total debt$4.7B+1.1%
Total equity-$241.1M-1,727%
Total assets$4.8B-4.8%

Cash flow

See full
Operating cash flow-$45.8M-52.3%
CapEx$46.8M+20.3%
Free cash flow-$92.5M-34.3%

Valuation

See full
Market cap$591.9M-10.0%
Enterprise value$5.22B
P/S0.6×

Profitability

See full
Gross margin73.2%-0.9pp
Operating margin-0.5%-0.3pp
Net margin-29.3%-12.7pp
FCF margin-10.6%

Returns & leverage

See full
Return on equity-198.7%-274pp
Debt / equity310.9×+307×
Current ratio1.3×+0.3×

Where this comes from

Calculated from CTEV’s reported figures.

Based on the most recent quarter.

The official record: CTEV’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CTEV's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CTEV's EV / EBITDA?
CTEV (CTEV) reported EV / EBITDA of 10.4× in Q1 2026.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.